Condensed Consolidated Statements of Equity (Unaudited) - USD ($)	Boyalife Investment Fund II, Inc. [Member] Common Stock [Member]	Boyalife Investment Fund II, Inc. [Member] Additional Paid-in Capital [Member]	Boyalife Investment Fund II, Inc. [Member] Retained Earnings [Member]	Boyalife Investment Fund II, Inc. [Member] AOCI Attributable to Parent [Member]	[1]	Boyalife Investment Fund II, Inc. [Member] Noncontrolling Interest [Member]	Boyalife Investment Fund II, Inc. [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	[1]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2018								2,168,337
Balance at Dec. 31, 2018								$ 2,000	$ 235,888,000	$ (227,435,000)	$ (13,000)		$ (1,711,000)	$ 6,731,000
Stock-based compensation expense									81,000					81,000
Exercise of pre-funded warrants (in shares)								50,000
Exercise of pre-funded warrants									5,000					5,000
Discount due to beneficial conversion features									1,513,000					1,513,000
Foreign currency translation gain (loss)											(4,000)			(4,000)
Net loss										(1,871,000)			(176,000)	(2,047,000)
Reorganization of subsidiary and related change in non-controlling interest									(2,843,000)				2,843,000
Balance (in shares) at Mar. 31, 2019								2,218,337
Balance at Mar. 31, 2019								$ 2,000	234,644,000	(229,306,000)	(17,000)		956,000	6,279,000
Balance (in shares) at Dec. 31, 2018								2,168,337
Balance at Dec. 31, 2018								$ 2,000	235,888,000	(227,435,000)	(13,000)		(1,711,000)	6,731,000
Foreign currency translation gain (loss)														9,000
Balance (in shares) at Sep. 30, 2019								2,704,837
Balance at Sep. 30, 2019								$ 3,000	236,830,000	(232,885,000)	(4,000)		687,000	4,631,000
Balance (in shares) at Mar. 31, 2019								2,218,337
Balance at Mar. 31, 2019								$ 2,000	234,644,000	(229,306,000)	(17,000)		956,000	6,279,000
Stock-based compensation expense									125,000					125,000
Exercise of pre-funded warrants (in shares)								150,000
Exercise of pre-funded warrants									18,000					18,000
Discount due to beneficial conversion features									800,000					800,000
Issuance of common stock, net									756,000					756,000
Foreign currency translation gain (loss)											(3,000)			(3,000)
Net loss										(1,297,000)			(178,000)	(1,475,000)
Balance (in shares) at Jun. 30, 2019								2,368,337
Balance at Jun. 30, 2019								$ 2,000	236,343,000	(230,603,000)	(20,000)		778,000	6,500,000
Stock-based compensation expense									253,000					253,000
Exercise of pre-funded warrants (in shares)								216,500
Exercise of pre-funded warrants								$ 1,000	18,000					19,000
Conversion of note payable to common stock (in shares)								120,000
Conversion of note payable to common stock									216,000					216,000
Foreign currency translation gain (loss)											16,000			16,000
Net loss										(2,282,000)			(91,000)	(2,373,000)
Balance (in shares) at Sep. 30, 2019								2,704,837
Balance at Sep. 30, 2019								$ 3,000	236,830,000	(232,885,000)	(4,000)		687,000	4,631,000
Balance (in shares) at Dec. 31, 2019								2,843,601
Balance at Dec. 31, 2019								$ 3,000	237,313,000	(236,932,000)	2,000		530,000	916,000
Stock-based compensation expense									67,000					67,000
Exercise of pre-funded warrants (in shares)								100,000
Exercise of pre-funded warrants									10,000					10,000
Exercise of warrants (in shares)								7,866
Exercise of warrants									47,000					47,000
Discount due to beneficial conversion features									1,869,000					1,869,000
Conversion of note payable to common stock (in shares)	1,666,670							100,000
Conversion of note payable to common stock	$ 2,000	$ 2,998,000					$ 3,000,000		180,000					180,000
Issuance of common stock, net (in shares)								1,050,748
Issuance of common stock, net								$ 1,000	3,220,000					3,221,000
Foreign currency translation gain (loss)											38,000			38,000
Net loss										(4,602,000)			(141,000)	(4,743,000)
Balance (in shares) at Mar. 31, 2020								5,768,885
Balance at Mar. 31, 2020								$ 6,000	245,704,000	(241,534,000)	40,000		389,000	4,605,000
Balance (in shares) at Dec. 31, 2019								2,843,601
Balance at Dec. 31, 2019								$ 3,000	237,313,000	(236,932,000)	2,000		530,000	916,000
Foreign currency translation gain (loss)														20,000
Balance (in shares) at Sep. 30, 2020								6,832,040
Balance at Sep. 30, 2020								$ 7,000	253,537,000	(250,434,000)	22,000		170,000	3,302,000
Balance (in shares) at Mar. 31, 2020								5,768,885
Balance at Mar. 31, 2020								$ 6,000	245,704,000	(241,534,000)	40,000		389,000	4,605,000
Stock-based compensation expense									314,000					314,000
Exercise of pre-funded warrants (in shares)								224,445
Exercise of pre-funded warrants									22,000					22,000
Exercise of warrants (in shares)								267,271
Exercise of warrants									1,604,000					1,604,000
Discount due to beneficial conversion features									3,112,000					3,112,000
Conversion of note payable to common stock (in shares)								104,445
Conversion of note payable to common stock								$ 1,000	188,000					189,000
Issuance of common stock, net (in shares)								344,419
Issuance of common stock, net									1,993,000					1,993,000
Foreign currency translation gain (loss)											1,000			1,000
Net loss										(6,437,000)			(73,000)	(6,510,000)
Balance (in shares) at Jun. 30, 2020								6,709,465
Balance at Jun. 30, 2020								$ 7,000	252,937,000	(247,971,000)	41,000		316,000	5,330,000
Stock-based compensation expense									234,000					234,000
Issuance of common stock, net (in shares)								122,575
Issuance of common stock, net									366,000					366,000
Foreign currency translation gain (loss)											(19,000)			(19,000)
Net loss										(2,463,000)			(146,000)	(2,609,000)
Balance (in shares) at Sep. 30, 2020								6,832,040
Balance at Sep. 30, 2020								$ 7,000	$ 253,537,000	$ (250,434,000)	$ 22,000		$ 170,000	$ 3,302,000

[1] Accumulated other comprehensive loss.